Categories
The FDA is issuing this update to inform the health care community of the final PAS results and updated labeling for the Impella RP System by Abiomed.
Categories
Getinge’s Maquet/Datascope IABP Devices: Update on Device Failure – Letter to Health Care Providers
The FDA is updating information about Getinge’s Maquet/Datascope IABP devices including information about three voluntary recalls.
Categories
Getinge Maquet/Datascope Intra-Aortic Balloon Pump (IABP) Shortage – Letter to Health Care Providers
The FDA is alerting health care facilities and providers of a shortage of Getinge Maquet/Datascope Intra-Aortic Balloon Pump (IABP) devices, including limited supplies of IAB catheters, new Cardiosave IABPs, and Cardiosave IABP parts.
Categories
FDA Approves First Fecal Microbiota Product
FDA Approves First Fecal Microbiota Product
http://www.fda.gov/news-events/press-announcements/fda-approves-first-fecal-microbiota-product
Categories
FDA Roundup: November 29, 2022
FDA Roundup: November 29, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-november-29-2022
Categories
Exela Pharma Sciences, LLC Expands Voluntary Nationwide Recall of Sodium Bicarbonate Injection, USP, 8.4%, 50 mEq/50 mL Vial, 20-Count Carton due to Vial Breakage UPDATED November 28, 2022
Lenoir, North Carolina. Exela Pharma Sciences, LLC, (Exela) is expanding their recall, adding fourteen (14) lots to the ongoing voluntary recall of forty-nine (49) lots of Sodium Bicarbonate Injection, USP, 8.4%, 50 mEq/50 mL vial, 20-count carton. A total of 63 lots are now being recalled to the c
Categories
Baxter Hillrom Recalls WatchCare Incontinence Management System (IMS) for Risk of RF Interference with Nearby Medical Equipment
The WatchCare IMS includes hospital beds and disposable incontinence pads. Radiofrequency emissions from the system may interfere with other medical devices.
Categories
Prolia (denosumab) by Amgen: Drug Safety Communication – FDA Investigating Risk of Severe Hypocalcemia in Patients on Dialysis
FDA is investigating the risk of severe hypocalcemia with serious outcomes, including hospitalization and death, in patients with advanced kidney disease on dialysis treated with the osteoporosis medicine Prolia (denosumab).
Categories
FDA Roundup: November 22, 2022
FDA Roundup: November 22, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-november-22-2022
Categories
FDA Approves First Gene Therapy to Treat Adults with Hemophilia B
FDA Approves First Gene Therapy to Treat Adults with Hemophilia B
http://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapy-treat-adults-hemophilia-b